# Trophoblast Extracellular Vesicles as Modulators of Keratinocyte Stress Response and Senescence

**Authors:** Mirjana Nacka-Aleksić, Andrea Pirković, Aleksandra Vilotić, Maja Kosanović, Dragana Dekanski, Janko Legner, Milica Jovanović Krivokuća

PMC · DOI: 10.3390/life15060918 · 2025-06-05

## TL;DR

Trophoblast extracellular vesicles may help reduce stress and aging in skin cells, potentially improving wound healing and anti-aging treatments.

## Contribution

This study is the first to investigate the effects of trophoblast-derived extracellular vesicles on D-galactose-induced keratinocyte aging.

## Key findings

- TEV pretreatment reduced stress and senescence markers in keratinocytes under D-galactose stress.
- TEVs enhanced keratinocyte proliferation and integrin-β1 expression, likely aiding wound healing.
- TEVs showed regenerative and protective potential for premature aging-related skin conditions.

## Abstract

Keratinocyte stress, caused by various intrinsic and extrinsic factors, contributes to the overall aging process. D-galactose-induced metabolic/oxidative stress is a commonly used in vitro model for studying premature aging. Due to their rich composition of bioactive molecules that influence critical pathways in cellular aging and rejuvenation, placental derivatives have a well-established history in anti-aging skincare and therapy. However, trophoblast-derived extracellular vesicle (TEV) effects on D-galactose-induced premature aging in keratinocytes have not been investigated yet. TEV pretreatment for 24 h enhanced cellular resilience against D-galactose-induced stress, judging by the downregulated expression of senescence- and stress-associated markers (p19 and p21, HIF-1α, mTOR), and reduced production of reactive oxygen species and DNA damage. Additionally, TEV pretreatment enhanced keratinocyte proliferation and integrin-β1 subunit expression upon D-galactose exposure, most likely contributing to more efficient wound closure. In conclusion, this study underscores the potential of TEVs to modify expression of stress- and senescence-related proteins in keratinocytes and improve their wound healing properties. Their regenerative and protective characteristics position TEVs as promising candidates for developing innovative procedures to address skin conditions related to premature aging.

## Linked entities

- **Genes:** CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029], CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475]
- **Chemicals:** D-galactose (PubChem CID 206)

## Full-text entities

- **Genes:** HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, IL23A (interleukin 23 subunit alpha) [NCBI Gene 51561] {aka IL-23, IL-23A, IL23P19, P19, SGRF}
- **Chemicals:** D-galactose (MESH:D005690), reactive oxygen species (MESH:D017382)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12194262/full.md

---
Source: https://tomesphere.com/paper/PMC12194262